Once-Daily Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Sex

August 2020 | Volume 19 | Issue 8 | Original Article | 777 | Copyright © August 2020


Published online July 23, 2020

Leon H. Kircik MD,a-c Linda Stein Gold MD,d Kenneth Beer MD,e Jerry Tan MD,f Hilary Baldwin MD,g Eric Guenin PharmD PhD MPH,h Robert Kang MS,i Johnson Varughesei

aIndiana University School of Medicine, Indianapolis, IN bPhysicians Skin Care, PLLC, Louisville, KY cIcahn School of Medicine at Mount Sinai, New York, NY dHenry Ford Hospital, Detroit, MI eUniversity of Miami Miller School of Medicine, Miami, FL fSchulich School of Medicine & Dentistry, Western University and Windsor Clinical Research Inc, Windsor, Ontario, Canada gThe Acne Treatment and Research Center, Brooklyn, NY hOrtho Dermatologics*, Bridgewater, NJ iBausch Health US, LLC*, Bridgewater, NJ *Bausch Health US, LLC is an affiliate of Bausch Health Companies Inc. Ortho Dermatologics is a division of Bausch Health US, LLC.